cpg glp-1 news How Is Reshaping Consumer Behavior + Branding CPG Shake-Up: Tariffs and GLP-1

Novel insights into GIP receptor targeting treatment reveal that both GIP receptor antagonists and agonists, when combined with glucagon like peptide 1 (GLP-1) receptor activation, are associated with improved glycemic control and weight loss

previous episodes of jaundice Risk factors : Female sex, age over 40, obesity, rapid previous weight loss, pregnancy history, family history of gallstones, certain ethnicities (Native American, Hispanic heritage) Physical examination : Right upper quadrant tenderness, Murphy's sign (inspiratory arrest during right subcostal palpation) Laboratory testing : Liver function tests may be considered based on clinical judgment to establish baseline and screen for biliary obstruction Imaging considerations : Routine abdominal ultrasound before starting weight loss injections is not recommended for asymptomatic patients

Tetracycline Antibiotics Calcium seems to reduce the absorption of tetracycline antibiotics

Safety data in humans is not as robust as it is for FDA approved medications